The United Kingdom's stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines amid concerns over weak trade data from China, a key trading partner. In such uncertain times, investors often seek out growth companies with high insider ownership as these stocks can indicate strong confidence from those closest to the business and potential resilience in volatile markets.
Top 10 Growth Companies With High Insider Ownership In The United Kingdom
| Name | Insider Ownership | Earnings Growth |
| Gulf Keystone Petroleum (LSE:GKP) | 12.4% | 59.2% |
| QinetiQ Group (LSE:QQ.) | 13.1% | 30.1% |
| Integrated Diagnostics Holdings (LSE:IDHC) | 27.9% | 20% |
| Audioboom Group (AIM:BOOM) | 15.6% | 59.3% |
| Judges Scientific (AIM:JDG) | 10.7% | 24.4% |
| Mortgage Advice Bureau (Holdings) (AIM:MAB1) | 19.8% | 20.3% |
| B90 Holdings (AIM:B90) | 24.4% | 166.8% |
| Hochschild Mining (LSE:HOC) | 38.4% | 24.7% |
| Faron Pharmaceuticals Oy (AIM:FARN) | 21.1% | 56.8% |
| Anglo Asian Mining (AIM:AAZ) | 40% | 116.2% |
Let's dive into some prime choices out of the screener.
Faron Pharmaceuticals Oy (AIM:FARN)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Faron Pharmaceuticals Oy is a clinical-stage drug discovery and development company with a market cap of £264.83 million.
Operations: Faron Pharmaceuticals Oy operates as a clinical-stage drug discovery and development company without any reported revenue segments in millions of €.
Insider Ownership: 21.1%
Earnings Growth Forecast: 56.8% p.a.
Faron Pharmaceuticals Oy, a growth-oriented company with significant insider ownership, recently engaged in a EUR 15 million convertible bond arrangement to bolster its financial position. Despite reporting a net loss of EUR 25.92 million for 2024 and facing auditor concerns about its going concern status, the company's revenue is expected to grow at an impressive rate of 55.4% annually, surpassing UK market averages. Leadership changes include appointing Dr Juho Jalkanen as CEO and Mr Colin Bond as Non-executive Director.
- Navigate through the intricacies of Faron Pharmaceuticals Oy with our comprehensive analyst estimates report here.
- Our comprehensive valuation report raises the possibility that Faron Pharmaceuticals Oy is priced higher than what may be justified by its financials.
M&C Saatchi (AIM:SAA)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: M&C Saatchi plc offers advertising and marketing communications services across the UK, Europe, the Middle East, Asia Pacific, and the Americas with a market cap of £192.12 million.
Operations: M&C Saatchi plc generates its revenue through providing advertising and marketing communications services across various regions including the UK, Europe, the Middle East, Asia Pacific, and the Americas.
Insider Ownership: 15.6%
Earnings Growth Forecast: 25.2% p.a.
M&C Saatchi, with substantial insider ownership, recently became profitable and is expected to see earnings grow significantly at 25.22% annually over the next three years, outpacing the UK market. Despite an anticipated revenue decline of 15.8% per year, its stock trades at a significant discount to fair value and analysts forecast a price increase of 55.7%. Upcoming leadership changes include Dame Heather Rabbatts as interim Non-Executive Chair following Zillah Byng-Thorne's departure.
- Dive into the specifics of M&C Saatchi here with our thorough growth forecast report.
- Upon reviewing our latest valuation report, M&C Saatchi's share price might be too pessimistic.
Property Franchise Group (AIM:TPFG)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: The Property Franchise Group PLC manages and leases residential real estate properties in the United Kingdom with a market cap of £283.06 million.
Operations: The company's revenue is derived from licensing (£7.21 million), financial services (£19.20 million), and property franchising (£40.90 million) segments.
Insider Ownership: 13.5%
Earnings Growth Forecast: 29.2% p.a.
Property Franchise Group, with substantial insider ownership, forecasts significant earnings growth of 29.23% annually over the next three years, surpassing UK market expectations. Despite a decline in profit margins from 27.1% to 15.1%, revenue is projected to grow at 13% annually, outpacing the broader market's growth rate of 3.9%. Recent financial results show increased sales and net income year-on-year; however, insider selling has been significant in recent months despite trading below estimated fair value by 37.9%.
- Get an in-depth perspective on Property Franchise Group's performance by reading our analyst estimates report here.
- Our valuation report unveils the possibility Property Franchise Group's shares may be trading at a discount.
Next Steps
- Gain an insight into the universe of 63 Fast Growing UK Companies With High Insider Ownership by clicking here.
- Searching for a Fresh Perspective? Uncover 16 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're here to simplify it.
Discover if Faron Pharmaceuticals Oy might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com